WO2004085392A8 - Melatonin derivatives and their use for treating neurological dysfunctions - Google Patents

Melatonin derivatives and their use for treating neurological dysfunctions

Info

Publication number
WO2004085392A8
WO2004085392A8 PCT/EP2004/003119 EP2004003119W WO2004085392A8 WO 2004085392 A8 WO2004085392 A8 WO 2004085392A8 EP 2004003119 W EP2004003119 W EP 2004003119W WO 2004085392 A8 WO2004085392 A8 WO 2004085392A8
Authority
WO
WIPO (PCT)
Prior art keywords
treating neurological
cycloalkyl
neurological dysfunctions
melatonin derivatives
moiety
Prior art date
Application number
PCT/EP2004/003119
Other languages
French (fr)
Other versions
WO2004085392A1 (en
Inventor
Stephan Schann
Pascal Neuville
Original Assignee
Faust Pharmaceuticals
Stephan Schann
Pascal Neuville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faust Pharmaceuticals, Stephan Schann, Pascal Neuville filed Critical Faust Pharmaceuticals
Publication of WO2004085392A1 publication Critical patent/WO2004085392A1/en
Publication of WO2004085392A8 publication Critical patent/WO2004085392A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to compounds of the general formula (1): wherein R1, R2, R3, R4 and R5 are H or a moiety of the formula : -(R6)n-R7; with R6 is a is an alkyl chain and R7 is, a moiety selected in the group consisting of -Cn,H2n2,+I, a cycloalkyl moiety, -N(Cn,H2n,+I)(Cn,H2n,+1), -NH-cycloalkyl, -O(Cn,H2n'+I), -0-cycloalkyl, =O, =S, -NO2, -I, -Br, -Cl, -F, -CF3, -OCF3, -COOH, -S03H, -P03H2, -CN, A3 and A4 are, C, N,O or S;m is from 0 to 2; and to their use for the treatment and/or prevention of diseases and conditions mediated by the imbalance of acetylcholine, and for treating and/or preventing glutamate excitotoxicity.
PCT/EP2004/003119 2003-03-25 2004-03-24 Melatonin derivatives and their use for treating neurological dysfunctions WO2004085392A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03360041 2003-03-25
EP03360041.2 2003-03-25

Publications (2)

Publication Number Publication Date
WO2004085392A1 WO2004085392A1 (en) 2004-10-07
WO2004085392A8 true WO2004085392A8 (en) 2004-12-23

Family

ID=33041125

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/003119 WO2004085392A1 (en) 2003-03-25 2004-03-24 Melatonin derivatives and their use for treating neurological dysfunctions

Country Status (1)

Country Link
WO (1) WO2004085392A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2838667A1 (en) * 2011-06-16 2012-12-20 President And Fellows Of Harvard College Novel rodent control agents and uses thereof
KR20130084047A (en) * 2012-01-16 2013-07-24 전북대학교산학협력단 Novel use of melatonin
EP3455223B1 (en) * 2016-05-12 2023-11-08 Buck Institute for Research on Aging Compounds to promote normal processing of app
GB201907871D0 (en) 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
WO2021089872A1 (en) 2019-11-07 2021-05-14 Small Pharma Ltd Compounds
US20210378969A1 (en) 2020-06-02 2021-12-09 Small Pharma Ltd. Therapeutic solid dosage forms
US11773062B2 (en) 2021-03-22 2023-10-03 Small Pharma Ltd Deuterated compounds
US11406619B2 (en) 2020-08-28 2022-08-09 Small Pharma Ltd Injectable formulations
US11660289B2 (en) 2020-12-01 2023-05-30 Small Pharma Ltd. Deuterated or partially deuterated N,N-dimethyltryptamine compounds
US11697638B2 (en) 2021-09-08 2023-07-11 Small Pharma Ltd 5-methoxy-N,N-dimethyltryptamine crystalline forms
CN113968810B (en) * 2021-11-11 2023-06-16 河北维达康生物科技有限公司 Preparation method of N, N-dimethyl-5-hydroxytryptamine
CN115124449B (en) * 2022-05-24 2024-02-02 上海英诺富成生物科技有限公司 Indole compound and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737725B1 (en) * 1995-08-08 1997-10-31 Valentonine NOVEL ACYLATED DERIVATIVES OF MELATONIN AND MELATONINERGIC ANALOGS, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
FR2787447B1 (en) * 1998-12-18 2001-03-23 Centre Nat Rech Scient NOVEL MELATONIN DERIVATIVES AND MEDICINAL PRODUCT COMPRISING SUCH DERIVATIVES

Also Published As

Publication number Publication date
WO2004085392A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
WO2004085392A8 (en) Melatonin derivatives and their use for treating neurological dysfunctions
NO20072665L (en) Rapamycin derivatives and their use in the treatment of neurological disorders
WO2007078523A3 (en) 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
NO20072664L (en) Rapamycin analogues and their applications for the treatment of neurological, proliferative and inflammatory disorders
BRPI0510365A (en) compound, method of producing a compound, nk2 receptor antagonist, prodrug, pharmaceutical agent, methods for antagonizing an nk2 receptor and preventing or treating functional gastrointestinal disorders, and use of the compound or a prodrug thereof
NO20033145D0 (en) Purine derivatives as purinergic receptor antagonists
NO20073019L (en) Pyrasolone compounds as metabotropic glutamate receptor antagonists for the treatment of neurotic and psychiatric disorders
BRPI0415960A (en) compound or a salt thereof, prodrug of a compound, pharmaceutical agent, peptidase inhibitor, compound or salt thereof, prodrug of a compound, pharmaceutical agent, peptidase inhibitor, use of a compound, and method to produce a compound
WO2007018998A3 (en) Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
TW200613272A (en) Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
EA200501585A1 (en) DERIVATIVES OF AZETIDINCARBOXAMIDE AND THEIR APPLICATION IN THE TREATMENT OF DISORDERS MEDIATED BY SV1 RECEPTORS
HK1101178A1 (en) Alkynyl derivatives as modulators of metabotropic glutamate receptors
WO2007140385A3 (en) Thiazole compounds as cannabinoid receptor ligands and uses thereof
BRPI0507495A (en) compound, pharmaceutical composition, use of the compound method for the treatment of mglur5-mediated disorders, and method for inhibiting activation of mglur5 receptors
WO2007079470A3 (en) Therapeutic amine-arylsulfonamide conjugate compounds
WO2008115999A8 (en) Biaryl and biheteroaryl compounds useful in treating iron disorders
TW200635594A (en) Phenyl-piperazin methanone derivatives
WO2007025897A3 (en) Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
BR0213067A (en) Heterocyclic Compounds for Use in the Treatment of Urinary Tract Disorders
WO2009137334A3 (en) Method for treating neurodegenerative dysfunction
DE60014136D1 (en) SAPOGENINE DERIVATIVES FOR TREATING COGNITIVE DISORDERS
WO2006050861A3 (en) Statine derivatives for the treatment of alzheimer's disease
EA200801536A1 (en) NEW TIENOPYRESULPHONE DERIVATIVES
WO2005060693A3 (en) 9-desoxoerythromycin compounds as prokinetic agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
122 Ep: pct application non-entry in european phase